Advertisement
Original research article| Volume 88, ISSUE 3, P382-386, September 2013

Effect of topical vaginal products on the detection of prostate-specific antigen, a biomarker of semen exposure, using ABAcards

  • Margaret C. Snead
    Correspondence
    Corresponding author. Centers for Disease Control and Prevention, Atlanta, GA 30341. Tel.: +1 770 488 6303; fax: +1 770 488 6391.
    Affiliations
    Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, and the Division of Scientific Resources, National Center for Emerging and Ζοοnotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Search for articles by this author
  • Athena P. Kourtis
    Affiliations
    Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, and the Division of Scientific Resources, National Center for Emerging and Ζοοnotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Search for articles by this author
  • Carolyn M. Black
    Affiliations
    Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, and the Division of Scientific Resources, National Center for Emerging and Ζοοnotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Search for articles by this author
  • Christine K. Mauck
    Affiliations
    CONRAD, Eastern Virginia Medical School (EVMS), Arlington, VA 23501, USA
    Search for articles by this author
  • Teresa M. Brown
    Affiliations
    Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, and the Division of Scientific Resources, National Center for Emerging and Ζοοnotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Search for articles by this author
  • Ana Penman-Aguilar
    Affiliations
    Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, and the Division of Scientific Resources, National Center for Emerging and Ζοοnotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Search for articles by this author
  • Johan H. Melendez
    Affiliations
    Johns Hopkins University, Department of Infectious Diseases, Baltimore, MD 21224, USA
    Search for articles by this author
  • Maria F. Gallo
    Affiliations
    Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, and the Division of Scientific Resources, National Center for Emerging and Ζοοnotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Search for articles by this author
  • Denise J. Jamieson
    Affiliations
    Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, and the Division of Scientific Resources, National Center for Emerging and Ζοοnotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Search for articles by this author
  • Maurizio Macaluso
    Affiliations
    Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA
    Search for articles by this author

      Abstract

      Background

      Prostate-specific antigen (PSA) is a biomarker of recent semen exposure. There is currently only limited information on whether topical vaginal products affect PSA assays. We investigated this question using various dilutions of several vaginal products (lubricants and spermicides) and the Abacus ABAcard for PSA detection.

      Study Design

      Pooled semen controls and various dilutions of nonoxynol-9 (N9), carboxymethyl cellulose (CMC), Replens, Gynol 2, K-Y jelly, Astroglide, Surgilube, combined with pooled semen dilutions, were tested for PSA using the Abacus ABAcard.

      Results

      N9 (2% with saline) and CMC did not appear to affect the results of testing with the ABAcard, but not all semen dilutions were tested. The other products (including Replens and Gynol, which is 2% N9 with propylene glycol, K-Y, Astroglide and Surgilube) at some of the dilutions tested either affected or gave invalid results with PSA testing using the ABAcard. Both Gynol 2 and K-Y at 1:10 dilution gave false-positive results.

      Conclusions

      Some vaginal products affect PSA results obtained by using the semiquantitative ABAcard. In vivo confirmation is necessary to further optimize PSA detection when topical vaginal products are present.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Contraception
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Mauck C.K.
        • Doncel G.F.
        Biomarkers of semen in the vagina: applications in clinical trials of contraception and prevention of sexually transmitted pathogens including HIV.
        Contraception. 2007; 75: 407-419
      1. Gallo MF, Steiner MJ, Hobbs MM, Warner L, Jamieson DJ, Macaluso M. Biological markers of semen exposure: tools for improving the assessment of sexual behavior in HIV/STI prevention research. [submitted to AIDS & Behav] 2012.

        • Graves H.
        • Sensabaugh G.
        • Blake E.
        Postcoital detection of a male-specific semen protein. Application to the investigation of rape..
        N Engl J Med. 1985; 312: 338-343
        • Mauck C.K.
        • Weaver M.A.
        • Schwartz J.L.
        • Walsh T.
        • Joanis C.
        Critical next steps for female condom research–report from a workshop.
        Contraception. 2009; 79: 339-344
        • Rountree R.W.
        • Kilbourne-Brook M.
        • Mauck C.K.
        • et al.
        SILCS diaphragm: postcoital testing of a new single-size contraceptive device.
        Contraception. 2008; 78: 237-244
        • Culhane J.F.
        • Nyirjesy P.
        • McCollum K.
        • Casabellata G.
        • Di Santolo M.
        • Cauci S.
        Evaluation of semen detection in vaginal secretions: comparison of four methods.
        Am J Reprod Immunol. 2008; 60: 274-281
      2. Abacus Diagnostics, West Hills, CA. ABAcard [cited 2012 April 27].
        (Available from)
        • Hochmeister M.N.
        • Budowle B.
        • Rudin O.
        • et al.
        Evaluation of prostate-specific antigen (PSA) membrane test assays for the forensic identification of seminal fluid.
        J Forensic Sci. 1999; 44: 1057-1060
        • Hobbs M.M.
        • Steiner M.J.
        • Rich K.D.
        • et al.
        Good performance of rapid prostate-specific antigen test for detection of semen exposure in women: implications for qualitative research.
        Sex Transm Dis. 2009; 36: 501-506
      3. Abbott Diagnostics, Abbott Park, IL. ARCHITECT i2000SR [cited 2012 April 27].
        (Available from)
        • Galva˜oa L.W.
        • Oliveirac L.C.
        • Dı´az J.
        • et al.
        Effectiveness of female and male condoms in preventing exposure to semen during vaginal intercourse: a randomized trial.
        Contraception. 2005; 71: 130-136
        • Macaluso M.
        • Lawson L.M.
        • Hortin G.
        • et al.
        Efficacy of the female condom as a barrier to semen during intercourse.
        Am J Epidemiol. 2003; 157: 289-297
        • Macaluso M.
        • Lawson L.
        • Akers R.
        • et al.
        Prostate-specific antigen in vaginal fluid as a biologic marker of condom failure.
        Contraception. 1999; 59: 195-201
      4. WHO Clinical management of rape survivors: developing protocols for use with refugees and internally displaced persons -- Revised ed. Annex 7 Forensic Examination Page 52; [cited 2012 April 27].
        (Available from)
        • Maher J.
        • Vintiner S.
        • Elliot D.
        • Melia L.
        Evaluation of the BioSign PSA membrane test for the identification of semen stains in forensic casework.
        N Z Med J. 2002; 115: 48-49
        • Sutton J.G.
        • Bosley C.
        • Rands A.
        The detection by Enzyme Linked Immunosorbent Assay of P30 and 19-OH Prostaglandin F1/F2, in the presence of a range of possible contaminants.
        Sci Justice. 1998; 38: 157-164
        • Jothnson E.D.
        • Kotowski T.M.
        Detection of prostate specific antigen by ELISA.
        J Forensic Sci. 1993; 38: 250-258
        • Stowell L.I.
        • Sharman L.E.
        • Hamel K.
        An enzyme-linked immunosorbent assay (ELISA) for prostate-specific antigen.
        Forensic Sci Int. 1991; 50: 125-138
        • Melendez J.H.
        • Doncel G.F.
        • Chaney D.
        • Schwartz J.L.
        • Snead M.C.
        • Mauck C.K.
        • et al.
        Inhibitory effect of lubricants and a vaginal contraceptive gel on detection of biomarkers of semen exposure. [abstract]. International Society for STD Research, London2009
        • Kristaly A.
        • Smith D.
        Validation of the One Step ABAcard TM PSA test for the rapid forensic identification of semen. Report from Miami Dade Police Department, 1998
        • Pang B.C.
        • Cheung B.K.
        Identification of human semenogelin in membrane strip test as an alternative method for the detection of semen.
        Forensic Sci Int. 2007; 169: 27-31
        • Bitner S.E.
        False positives observed on the Seratec(®) PSA semiquant cassette test with condom lubricants.
        J Forensic Sci. 2012; ([Epub ahead of print])
        • Laffan A.
        • Sawyer I.
        • Quinones I.
        • Daniel B.
        Evaluation of semen presumptive tests for use at crime scenes.
        Med Sci Law. 2011; 51: 11-17
        • Hobbs M.M.
        • Steiner M.J.
        • Rich K.D.
        • Gallo M.F.
        • Warner L.
        • Macaluso M.
        Vaginal swab specimen processing methods influence performance of rapid semen detection tests: a cautionary tale.
        Contraception. 2010; 82 ([Epub 2010 Apr 13]): 291-295
        • Gallo M.F.
        • Steiner M.J.
        • Hobbs M.M.
        • et al.
        Predictors of unprotected sex among female sex workers in Madagascar: comparing semen biomarkers and self-reported data.
        AIDS Behav. 2010; 14: 1279-1286
        • Minnis A.M.
        • Steiner M.J.
        • Gallo M.F.
        • Warner L.
        • Hobbs M.M.
        • van der Straten A.
        • et al.
        Biomarker validation of reports of recent sexual activity: results of a randomized controlled study in Zimbabwe.
        Am J Epidemiol. 2009; 170: 918-924